Kindred Biosciences to Announce First Quarter 2018 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Tuesday, May 8, 2018 San Francisco, CA (April 18, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its first quarter 2018 […]

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

SAN FRANCISCO, Mar. 8, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Oppenheimer 28th Annual Healthcare Conference on March 20-21, 2018 in New York City. Denise Bevers, Co-Founder and Chief Operating Officer, will present and be available for one-on-one […]

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

San Francisco, CA (March 1, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the fourth quarter and full year ended December 31, 2017 and provided updates on its programs. “We continue to look forward to the upcoming approval of our […]

Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, March 1, 2018 San Francisco, CA (February 15, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its fourth quarter and […]

Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

SAN FRANCISCO, Feb. 13, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will participate in the Bank of America Merrill Lynch Animal Health Summit on February 26, 2018 in New York City. Richard Chin, M.D., President and Chief Executive Officer, will participate in […]